Company / Depreciation & Amortization
Disc Medicine, Inc. Depreciation & Amortization History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$281.0K
FY2025
5-year range
$32.0K / $281.0K
FY2021-FY2025
Trend
+80.1%
vs FY2024
Sector context
#146 of 163
Health Care
What the data says
Among 163 Health Care companies, Disc Medicine, Inc. is in the top 10% for depreciation & amortization. Depreciation & Amortization has increased for 4 consecutive years, from $32,000 in FY2021 to $281,000 in FY2025.
Based on SEC 10-K filings.
$281,000 in FY2025 with a 5-year CAGR of -2.7%.
Increased from $100,000 to $281,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +46.7%
- 5-Year CAGR
- -2.7%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 163This company $281.0K Sector average $219.4M
▼
-99.9% below sector average
Key checks
Key Insights
- Disc Medicine, Inc.'s depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of -2.7%, indicating a declining trend.
- In FY2025, depreciation & amortization increased 80.1% year-over-year.
- Ranks #146 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $281.0K | +80.1% |
| FY2024 | $156.0K | +56.0% |
| FY2023 | $100.0K | +12.4% |
| FY2022 | $89.0K | +178.1% |
| FY2021 | $32.0K | -90.1% |
| FY2020 | $322.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026